Researchers have found that central body fat, especially around the abdomen, is more strongly linked to psoriasis risk ...

Tirzepatide is now approved for the treatment of obstructive sleep apnea, highlighting the drug class' potential in sleep ...

Researchers have found that central body fat, especially around the abdomen, is more strongly linked to psoriasis risk than ...

A small study of Sanofi’s lixisenatide has suggested that the GLP-1 agonist could slow down the progression of Parkinson’s disease, pointing to another potential use for the fast-growing drug ...